statistiche ricercatore

MORA, BARBARA

Distribuzione geografica

Continente	#
NA - Nord America	2.719
EU - Europa	1.134
AS - Asia	988
SA - Sud America	94
AF - Africa	17
OC - Oceania	2
Continente sconosciuto - Info sul continente non disponibili	1
Totale	4.955

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	2.678
IT - Italia	528
SG - Singapore	379
CN - Cina	174
VN - Vietnam	159
UA - Ucraina	137
HK - Hong Kong	109
SE - Svezia	104
TR - Turchia	93
BR - Brasile	77
IE - Irlanda	67
DE - Germania	65
GB - Regno Unito	63
FR - Francia	41
FI - Finlandia	32
RU - Federazione Russa	31
CA - Canada	26
IN - India	17
JP - Giappone	16
BD - Bangladesh	13
MX - Messico	12
PL - Polonia	12
CZ - Repubblica Ceca	10
NL - Olanda	10
ZA - Sudafrica	10
ES - Italia	8
AR - Argentina	6
LT - Lituania	6
PK - Pakistan	6
BE - Belgio	5
AT - Austria	4
CL - Cile	4
KE - Kenya	3
SA - Arabia Saudita	3
TH - Thailandia	3
UZ - Uzbekistan	3
VE - Venezuela	3
EC - Ecuador	2
GR - Grecia	2
HU - Ungheria	2
IQ - Iraq	2
KR - Corea	2
KZ - Kazakistan	2
MD - Moldavia	2
NG - Nigeria	2
AE - Emirati Arabi Uniti	1
AL - Albania	1
AU - Australia	1
AZ - Azerbaigian	1
BG - Bulgaria	1
CH - Svizzera	1
CO - Colombia	1
CR - Costa Rica	1
DZ - Algeria	1
EU - Europa	1
GT - Guatemala	1
ID - Indonesia	1
JM - Giamaica	1
LB - Libano	1
MY - Malesia	1
NO - Norvegia	1
NZ - Nuova Zelanda	1
PS - Palestinian Territory	1
PY - Paraguay	1
RO - Romania	1
TN - Tunisia	1
TW - Taiwan	1
Totale	4.955

Salva come PNG Salva come JPEG

Città	#
Milan	375
Fairfield	323
Ashburn	255
Woodbridge	226
Singapore	206
Houston	164
Chandler	150
Seattle	150
San Jose	149
Jacksonville	121
Wilmington	121
Cambridge	116
Ann Arbor	113
Hong Kong	105
Nyköping	77
Dallas	71
Princeton	65
Dublin	64
Izmir	48
The Dalles	44
Boardman	43
Beijing	40
Dearborn	38
Lauterbourg	34
Dong Ket	33
San Diego	31
Hanoi	27
Ho Chi Minh City	25
Los Angeles	23
Como	22
Rome	22
London	21
Ogden	20
New York	19
Helsinki	18
Redmond	18
Orem	16
Kocaeli	13
Munich	13
Santa Clara	13
São Paulo	13
Tokyo	12
Toronto	12
Chicago	11
Warsaw	11
Council Bluffs	10
Brno	9
Brooklyn	9
Johannesburg	9
Mexico City	9
Atlanta	8
Frankfurt am Main	8
Poplar	8
Washington	8
Amsterdam	7
Varese	7
Chennai	6
Denver	6
Montreal	6
San Francisco	6
Ankara	5
Brussels	5
Dhaka	5
Guangzhou	5
Haiphong	5
Hefei	5
Manchester	5
Rio de Janeiro	5
Shanghai	5
City of London	4
Columbus	4
Da Nang	4
Falkenstein	4
Ha Long	4
Hangzhou	4
Jackson	4
Kilburn	4
Kunming	4
Ottawa	4
Redwood City	4
Cavaria con Premezzo	3
Concord	3
Gavirate	3
Islamabad	3
Mumbai	3
Nairobi	3
Nanchang	3
Nanjing	3
Norwalk	3
Nuremberg	3
Phoenix	3
Salt Lake City	3
Stockholm	3
Tashkent	3
Zhengzhou	3
Alvorada	2
Astana	2
Belo Horizonte	2
Biên Hòa	2
Boston	2
Totale	3.751

Salva come PNG Salva come JPEG

Nome	#
A clinical-molecular prognostic model to predict survival in patients with post polycythemia vera and post essential thrombocythemia myelofibrosis	242
Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts	235
Looking for CALR mutations in familial myeloproliferative neoplasms	220
A new acute myeloid leukemia case with STAT5B-RARA gene fusion due to 17q21.2 interstitial deletion	217
Involvement of MAF/SPP1 axis in the development of bone marrow fibrosis in PMF patients	215
It is time to change thrombosis risk assessment for PV and ET?	199
Developments in diagnosis and treatment of essential thrombocythemia	197
Driver mutations' effect in secondary myelofibrosis: An international multicenter study based on 781 patients	196
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project	196
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group	196
New molecular genetics in the diagnosis and treatment of myeloproliferative neoplasms	169
Immunogenicity of anti-SARS-CoV-2 Comirnaty vaccine in patients with lymphomas and myeloma who underwent autologous stem cell transplantation	165
Validation and further potentialities of the novel AWM score for progression risk stratification in patients with asymptomatic Waldenström macroglobulinemia	147
Post-ET and Post-PV Myelofibrosis: Updates on a Distinct Prognosis from Primary Myelofibrosis	144
Prognostication in myelofi-brosis	139
Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: results of a prospective cohort study of 365 patients	137
Therapy of polycythemia vera: Is it time to change?	133
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC project	132
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis	121
Polycythemia vera: From new, modified diagnostic criteria to new therapeutic approaches	120
Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection	120
Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients	119
MYD88L265P Detection in IgM Monoclonal Gammopathies: Methodological Considerations for Routine Implementation	118
Increased plasma levels of lncrnas linc01268, gas5 and malat1 correlate with negative prognostic factors in myelofibrosis	115
Phenotype variability of patients with post polycythemia vera and post essential thrombocythemia myelofibrosis is associated with the time to progression from polycythemia vera and essential thrombocythemia	112
Molecular profiling and risk classification of patients with myeloproliferative neoplasms and splanchnic vein thromboses	104
Is there a gender effect in polycythemia vera?	102
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study	102
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphoma	95
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis	93
COVID-19 elicits an impaired antibody response against SARS-CoV-2 in patients with haematological malignancies	93
Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi	82
The future of research in hematology: Integration of conventional studies with real-world data and artificial intelligence	82
Second primary malignancies in ruxolitinib-treated myelofibrosis: Real-world evidence from 219 consecutive patients	69
Platelet count predicts driver mutations’ co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis	68
Direct-acting antivirals in hepatitis C virus-positive mantle cell lymphomas	61
Totale	5.055

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	22.554
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	22.554

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	191	0	0	0	0	0	0	0	0	0	56	62	73
2021/2022	331	50	16	2	15	11	22	16	21	26	87	19	46
2022/2023	473	33	13	75	43	36	102	2	56	75	13	9	16
2023/2024	618	91	94	92	115	133	40	7	4	25	2	5	10
2024/2025	555	15	3	79	43	23	25	18	54	84	49	42	120
2025/2026	1.215	106	87	70	229	132	83	245	71	129	63	0	0
Totale													5.055